GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Beginning Cash Position

Rising Biosciences (Rising Biosciences) Beginning Cash Position : $0.00 Mil (As of . 20)


View and export this data going back to . Start your Free Trial

What is Rising Biosciences Beginning Cash Position?

Rising Biosciences's Beginning Cash Position for the quarter that ended in . 20 was $0.00 Mil.


Rising Biosciences Beginning Cash Position Historical Data

The historical data trend for Rising Biosciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Beginning Cash Position Chart

Rising Biosciences Annual Data
Trend
Beginning Cash Position

Rising Biosciences Quarterly Data
Beginning Cash Position

Rising Biosciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Rising Biosciences Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Rising Biosciences (Rising Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
1180 Cleveland Road, Sandusky, OH, USA, 44870
Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.

Rising Biosciences (Rising Biosciences) Headlines

From GuruFocus

PAOG Officially Appoints Karl Riedel as New CEO and President

By Marketwired Marketwired 02-11-2019